Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


c-myc promoter (TBE 1/2 - wt) Citations (3)

Originally described in: Identification of c-MYC as a target of the APC pathway.
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW Science. 1998 Sep 4. 281(5382):1509-12.
PubMed Journal

Articles Citing c-myc promoter (TBE 1/2 - wt)

The relationship between the Wnt/beta-catenin and TGF-beta/BMP signals in the intervertebral disc cell. Hiyama A, Sakai D, Tanaka M, Arai F, Nakajima D, Abe K, Mochida J. J Cell Physiol. 2011 May;226(5):1139-48. doi: 10.1002/jcp.22438. PubMed
Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFkappaB-cMyc-p21 pathway. Luo H, Rankin GO, Juliano N, Jiang BH, Chen YC. Food Chem. 2012 Jan 15;130(2):321-328. PubMed
Activation of c-Myc and Cyclin D1 by JCV T-Antigen and beta-catenin in colon cancer. Ripple MJ, Parker Struckhoff A, Trillo-Tinoco J, Li L, Margolin DA, McGoey R, Del Valle L. PLoS One. 2014 Sep 17;9(9):e106257. doi: 10.1371/journal.pone.0106257. eCollection 2014. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.